Company Description
Ending breast cancer is top priority at EndoCeutics. The trial-phase biopharmaceutical company develops hormone therapies for treating and...
Key EndoCeutics Financials
| Company Type | Private - NASDAQ (GM): ENCX Proposed Main Headquarters |
|---|---|
| Fiscal Year-End | December# |
| 2007 Sales (mil.) | $1.1 |
| 2007 Employees | 1 |
More EndoCeutics Financials (4 pages)
Competition
Competitive Landscape for Chemicals
Demand is driven by the health of the US economy because chemicals are used to make a wide variety of industrial and consumer products. The profitability of individual companies is closely tied to...
Read more about EndoCeutics's competition across multiple industries
Top EndoCeutics Competitors
Sponsored Links
The Business Directory
EndoCeutics Executives
| Title | Name & Bio | Contact |
|---|---|---|
| President, CEO, Chief Scientific Officer, and Director | Fernand Labrie | Network | E-mail |
| CFO | Claude Doré | Network | E-mail |
| COO | Jean-Denis Dubois | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Sponsored Opportunity
